In a Phase 2a trial focused on metabolic dysfunction-associated steatotic liver disease (MASLD, formerly called NAFLD), retatrutide delivered the following liver fat reductions: Read those numbers again
We celebrate small wins along the way and create personalized programs tailored to produce successful chronic weight management
B12 injections are safer than corticosteroids, so the slower treatment may be worth it for those in pain
For example, MR-Egger estimates for anxiety disorders (OR = 0.81, 95% CI: 0.591.11) and autism (OR = 0.62, 95% CI: 0.321.20) included the null value
:
RWD provides the depth and breadth needed to address critical questions, revealing how GLP-1s perform across medical histories, comorbidities, label expansions, and populations not studied in clinical trials (such as pregnant women)